newsfilter
← Latest News
ACCESS Newswire·

Ensysce Biosciences, Inc. Announces $1.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

SAN DIEGO, CA / ACCESS Newswire / March 31, 2025 / Ensysce Biosciences, Inc. , a clinical-stage pharmaceutical company developing innovative solutions for